Antibiotic Data to Inform Local Action (ADILA)

After the World Health Assembly endorsed the Global Action Plan on antimicrobial resistance (AMR) in 2015, countries were encouraged to develop National Action Plans (NAPs). By 2022, 148 countries had established a NAP, with 38 more in development. Evidence-based decision-making plays a central role in shaping, implementing, and evaluating NAPs. This requires not only the effective collection but also the optimal use of data on antibiotic consumption to inform prescribing practices and improve clinical outcomes aligned with local priorities. ADILA, a data re-use project focussing on using existing data better, aims to improve the quality of antibiotic use through developing a new framework for future target setting and implementation. Within the project, novel models and tools of collating and presenting data have been being developed to help inform local, national and global policy makers on potential interventions to improve the quality of antibiotic use. The project takes a risk based, burden adjusted approach to future policy development. The project is based on the World Health Organisation(WHO) Access-, Watch-, Reserve- (AWaRe) system. The project takes a global equity approach to antibiotic use, aiming to define levels of “Fair share of AWaRe” antibiotics.